Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1,976 $ 39,339,449 $ (51,771,667) $ (12,430,242)
Balance (in Shares) at Dec. 31, 2019 19,756,154      
Stock-based compensation 25,599 25,599
Forgiveness of accrued officers salary 150,002 150,002
Net loss (2,807,285) (2,807,285)
Balance at Mar. 31, 2020 $ 1,976 39,515,050 (54,578,952) (15,061,926)
Balance (in Shares) at Mar. 31, 2020 19,756,154      
Stock-based compensation 1,881,080 1,881,080
Net loss (3,220,541) (3,220,541)
Balance at Jun. 30, 2020 $ 1,976 41,396,130 (57,799,493) (16,401,387)
Balance (in Shares) at Jun. 30, 2020 19,756,154      
Balance at Dec. 31, 2020 $ 2,654 80,330,488 (65,249,547) 15,083,595
Balance (in Shares) at Dec. 31, 2020 26,540,769      
Stock-based compensation 1,348,462 1,348,462
Shares issued in exercise of warrants $ 13 1,279,879 1,279,892
Shares issued in exercise of warrants (in Shares) 131,271      
Forgiveness of accrued officers salary 135,103 135,103
Net loss (3,138,119) (3,138,119)
Balance at Mar. 31, 2021 $ 2,667 83,093,932 (68,387,666) 14,708,933
Balance (in Shares) at Mar. 31, 2021 26,672,040      
Issuance of shares from 2021 Public Offering, net of costs $ 736 47,522,833 47,523,569
Issuance of shares from 2021 Public Offering, net of costs (in Shares) 7,360,000      
Stock-based compensation 301,657 301,657
Shares issued in exercise of warrants $ 1 65,002 65,003
Shares issued in exercise of warrants (in Shares) 6,667      
Net loss (2,821,766) (2,821,766)
Balance at Jun. 30, 2021 $ 3,404 $ 130,983,424 $ (71,209,432) $ 59,777,396
Balance (in Shares) at Jun. 30, 2021 34,038,707